Conduction Disorders Before TAVR: What Is Their Impact?

Transcatheter aortic valve replacement (TAVR) has become an established treatment for severe aortic stenosis and is now performed in increasingly lower-risk populations.

Despite the use of high implant strategies, the need for permanent pacemaker implantation (PPI) remains a persistent challenge, particularly in patients with right bundle branch block (RBBB) and, to a lesser extent, in those with first-degree AV block (1st-degree AVB) or left bundle branch block (LBBB).

While PPI is considered a low-risk procedure, it is associated with longer hospital stays, increased hospital and follow-up costs, generator replacement needs, and a higher risk of endocarditis, tricuspid regurgitation, or other complications.

Researchers analyzed a cohort of 1069 patients who underwent TAVR. Of these, 825 (77.2%) had a preprocedural PR interval <240 ms, 44 (4.1%) had a PR interval >240 ms, 93 (8.7%) had LBBB, and 107 (10%) had RBBB.

The primary endpoint (PEP) was high-grade AV block (HAVB) at 30 days, defined as the presence of two non-conducted P waves in sinus rhythm or bradycardia <50 bpm in patients with atrial fibrillation or flutter.

Patients with conduction disorders were older and predominantly male, while women were more common in the group without conduction disturbances. Comorbidities were similar across groups, although patients with a PR interval >240 ms had a higher prevalence of myocardial revascularization surgery (MRS) and dialysis. Patients with LBBB experienced a higher incidence of diabetes and atrial fibrillation or flutter, and those with RBBB had a higher rate of prior MRS compared to the control group.

Read also: Statins and Small Abdominal Aortic Aneurysms: Unexpected Aid?

The STS mortality score was 5%. Ejection fraction averaged 60%, except in the LBBB group, where it was significantly lower (50%). The average aortic valve area was 0.8 cm². The most commonly used approach was the transfemoral access, and the most frequently implanted valve was the balloon-expandable valve (92%).

The PEP was significantly higher in patients with RBBB compared to those without conduction disorders (17.8% vs. 2.2%; p < 0.001). In the PR >240 ms and LBBB groups, the PEP was also higher, though without statistical significance (4.5% vs. 2.2%; p=0.31 and 5.4% vs. 2.2%; p=0.6, respectively).

The need for PPI was significantly higher in the RBBB and LBBB groups compared to the control group (39.2% vs. 6.1%; p <0.001 and 11.8% vs. 6.1%; p=0.03, respectively). In contrast, for patients with a PR interval >240 ms, the rate was similar to that for the control group (9.1% vs. 6.1%; p=0.42). Most HAVB episodes in the control group, as well as in the PR interval >240 ms and LBBB groups, occurred after 24 hours.

Read also: Coronary Events Following TAVI: A Registry.

Thirty-day mortality was higher in the RBBB group compared to the control group (2.8% vs. 0.5%; p=0.009), although there were no significant differences in one-year mortality among the four groups.

RBBB emerged as a predictor of high-grade AV block.

Conclusion

Despite no immediate ECG abnormalities following TAVR, 17.8% of patients with RBBB developed high-grade AV block, mostly within the first 24 hours. In contrast, its incidence was relatively low in patients with PR interval >240 ms or LBBB. Early discharge with outpatient ECG monitoring could be an appropriate strategy for these patients.

Original Title: Incidence and Predictors of High-Grade AV Block in Patients With Initially Unchanged Electrocardiogram After TAVR. 

Reference: Mohamed Elhadi, et al. JSCAI https://doi.org/10.1016/j.jscai.2025.103666. 


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Carlos Fava
Dr. Carlos Fava
Member of the Editorial Board of solaci.org

More articles by this author

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

The Two Sides of the Coin: What Do CHAMPION-AF and CLOSURE-AF Teach Us About Left Atrial Appendage Closure?

Letter to the editor: Juan Manuel Pérez Asorey Percutaneous left atrial appendage closure (LAAO) is currently going through one of the most interesting stages of...

CLOSURE-AF: Percutaneous Left Atrial Appendage Closure versus Medical Therapy in Atrial Fibrillation

Percutaneous left atrial appendage closure has been proposed as an alternative to anticoagulation in patients with atrial fibrillation and high bleeding risk; however, comparative...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...